Formulations of gamma hydroxybutyrate modified-release with improved pharmacokinetics

• 1. 在进食状态下具有改善的药代动力学的γ-羟基丁酸酯组合物 [P] . 中国专利： CN113473980A . 2021-10-01
• 2. 具有经改善药代动力学的γ-羟基丁酸盐改进释放制剂 [P] . 中国专利： CN109789096A . 2019-05-21
• 3. Modified-release gamma-hydroxybutyrate formulations with improved pharmacokinetics [P] . 日本专利： JP6683886B2 . 2020-04-22

  机译： 具有改善的药代动力学的缓释γ-羟基丁酸酯制剂

• 4. MODIFIED RELEASE GAMMA-HYDROXYBUTYRATE FORMULATIONS HAVING IMPROVED PHARMACOKINETICS [P] . US2022016066A1 . 2022-01-20

  机译： 改性释放γ-羟基丁酯配方，具有改进的药代动力学

• 5. Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics [P] . US11052061B2 . 2021-07-06

  机译： 改性释放γ-羟基丁酸盐配方，具有改进的药代动力学

• 1. Development of nanocrystal formulation of mebendazole with improved dissolution and pharmacokinetic behaviors [J] . Naofumi Hashimoto, Kayo Yuminoki, Haruka Takeuchi, 亚洲药物制剂科学(英文) . 2016,第001期
• 2. Virtual population pharmacokinetic using physiologically based pharmacokinetic model for evaluating bioequivalence of oral lacidipine formulations in dogs [J] . Bin Yang, Chunnuan Wu, Bin Ji, 亚洲药物制剂科学(英文) . 2017,第001期
• 3. Preparation of Thermosensitive Chitosan Formulations Containing 5-Fluorouracil/Poly-3-hydroxybutyrate Microparticles Used as Injectable Drug Delivery System [J] . 昝佳, 朱德权, 谭丰苹, 中国化学工程学报：英文版 . 2006,第002期
• 4. The influence of genetic polymorphisms in drug metabolism enzymes and transporters on the pharmacokinetics of different fluvastatin formulations [J] . Qian Xiang, Weidang Wu, Nan Zhao, 亚洲药物制剂科学(英文) . 2020,第002期
• 5. In vitro/vivo assessment of praziquantel nanocrystals: Formulation, characterization, and pharmacokinetics in beagle dogs [J] . Ruyi Yang, Tao Zhang, Jiang Yu, 亚洲药物制剂科学(英文) . 2019,第003期
• 6. Acid control cannot be improved with a modified-release formulation of a proton pump inhibitor compared with twice-daily dosing of the conventional formulation. [J] . Rohss K, Wilder Smith C, Bokelund Singh S, Digestive Diseases and Sciences . 2010,第12期
• 7. Acid Control Cannot Be Improved with a Modified-Release Formulation of a Proton Pump Inhibitor Compared with Twice-Daily Dosing of the Conventional Formulation [J] . Kerstin Röhss, Clive Wilder-Smith, Sara Bokelund-Singh, Digestive Diseases and Sciences . 2010,第12期
• 8. Pharmacokinetic analysis of modified-release metoprolol formulations: An interspecies comparison [J] . De Thaye Elien, Vervaeck Anouk, Marostica Eleonora, European journal of pharmaceutical sciences . 2017,第期
• 9. Formulation Development, Gammascintigraphy and Pharmacokinetic studies ofGastro-retentive Sustained Release System of Satranidazole for H.pylori Infection [C] . K. Kala, K. K. Singh Annual meeting exposition of the Controlled Release Society . 2009
• 10. 1. Pharmacokinetic modeling and simulations of gastrointestinal transit effects on drug pharmacokinetics from enteric-coated pellet formulations and their applications. 2. Development of crushable enteric-coated formulations. 3. Development of leaky enteric-coated pellets formulations. [D] . Watanalumlerd, Prapoch. 2004
• 11. Effect of food on the comparative pharmacokinetics of modified-release morphine tablet formulations: Oramorph SR and MST Continus [O] . J. DRAKE, C. T. KIRKPATRICK, C. A. ALIYAR, 1996
• 12. Pharmacokinetic analysis of modified-release metoprolol formulations : an interspecies comparison [O] . De Thaye, Elien, Vervaeck, Anouk, Marostica, Eleonora, 2017

• 1. 来源于Agrobacterium sp.DSGZ的聚(3-羟基丁酸酯-co-4-羟基丁酸酯)解聚酶的纯化及催化特性研究 [C] . 郭子琦 ,李凡 ,陈珊 . 第十七次全国环境微生物学学术研讨会 . 2014
• 2. 基于农作物组分的聚(3-羟基丁酸酯-co-4-羟基丁酸酯)力学调控 [A] . 陈兆曙 . 2017